- £1.45bn
- £1.42bn
- $230.99m
- 41
- 34
- 81
- 51
Annual income statement for BH Macro, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 204 | 53.9 | 375 | 189 | 231 |
Cost of Revenue | |||||
Gross Profit | 163 | 36.7 | 287 | 159 | 186 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 48.8 | 28.9 | 114 | 123 | 139 |
Operating Profit | 156 | 25.1 | 261 | 65.7 | 92 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 182 | 12 | 112 | 66.5 | 58.2 |
Net Income After Taxes | 182 | 12 | 112 | 66.5 | 58.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 182 | 12 | 112 | 66.5 | 58.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 182 | 12 | 112 | 66.5 | 58.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.06 | 0.058 | 0.358 | 0.174 | 0.142 |